Nawal Roy

Nawal Roy is founder and CEO of Holmusk. Holmusk is building the world’s largest real-world evidence platform for neurosciences. They leverage their technology to work with real-world data across the whole spectrum of chronic diseases.

Articles: Nawal Roy

Opinion: The Paradigm Shift Needed for Effective Alzheimer’s Treatments

Opinion / Holmusk’s Nawal Roy outlines why a cure for Alzheimer’s Disease is the “Holy Grail” of medicine today, the reasons for so many biotech companies failing to develop effective treatments for the disease, and why a more holistic systems approach may be the key to future success. The ingenuity of medical science has created effective…

Mental Health in China: A Tsunami Brewing?

Mental Health / “Mental health is currently a major problem in China, and will become an ever greater problem unless effective interventions are put in place.” Mental Health has Long Been a Serious Problem in China The most populous nation in the world is said by some to be “in the throes of a mental health…

Pharma Must Embrace Real-World Evidence to Remain Competitive

Opinion / Holmusk’s Nawal Roy highlights the increasing recognition of the value of real-world evidence (RWE) by both innovative pharma companies and drug regulators and its potential to increase market capture and profitability. RWE has the potential to expand the market size of a disease and accelerate market capture of a given therapeutic agent Following over…

Real-World Evidence – A Game Changer for Pharma

Opinion / Nawal Roy is founder and CEO of Holmusk, a company dedicated to building one of the world’s largest real-world evidence platforms for neurosciences. Here, Nawal Roy discusses the potential for real-world evidence to optimise drug life-cycle management. Use of real-world evidence (RWE) can modernize the process of drug research, development and delivery. The pharmaceutical industry spends a tremendous…